Rapid scale-up of a community-based HIV treatment service: Programme performance over 3 consecutive years in Guguletu, South Africa

South African Medical Journal

Volumn 96, Issue 4, 2006, Pages 315-320

  Bekker, Linda Gail ^a   Myer, Landon ^a   Orrell, Catherine ^a   Lawn, Steve ^a,b   Wood, Robin ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DAPSONE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CD4 LYMPHOCYTE COUNT; CHILD; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEALTH CARE DISTRIBUTION; HEALTH PRACTITIONER; HEALTH PROGRAM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PATIENT COMPLIANCE; PATIENT MONITORING; PUBLIC HEALTH SERVICE; SOUTH AFRICA; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PREGNANCY; PROGRAM EVALUATION; PROSPECTIVE STUDIES; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 33646012002     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. World Health Organization. Treating 3 million by 2005. Making it happen. The WHO strategy 2003. http://www.who.int/3by5/Publications/en/3by5StrategyMakingItHappen.pdf (last accessed 13 March 2006).
2. World Health Organization. Progress on Global Access to HIV Antiretroviral Therapy. An update on '3 by 5'. WHO June 2005. http://www.who.int/3by5/fullreportJune2005.pdf (last accessed 13 March 2006).
3. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001; 358: 410-414.
4. Laurent C, Diakhate N, Gueye NFN, et al. The Senegalese government's highly active antiretroviral therapy initiative: An 18-month follow-up study. AIDS 2002; 16: 1363-1370.
5. Weidle PJ, Malamba S, Mwebaze R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: Patients' response, survival, and drug resistance. Lancet 2002; 360: 34-40.
6. Djomand G, Roels T, Ellerbrock T, et al. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Cote d'Ivoire. AIDS 2003;17: suppl 3, S5-S15.
7. Seyler C, Anglaret X, Dakoury-Dogbo N, et al. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Cote d'Ivoire. Antivir Ther 2003; 8: 385-393.
8. Tassi J-M, Szumilin E, Calmy A, Goemaere E. Highly active antiretroviral therapy in resource-poor settings: The experience of Medecins Sans Frontieres. AIDS 2003; 17: 1995-1997.
9. Laurent C, Mello H, Gulard-Schmit J-B, et al. Antiretroviral therapy in public and private routine health care clinics in Cameroon: Lessons from the Douala Antiretroviral (DARVIR) Initiative. Clin Infect Dis 2005; 41: 108-111.
10. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18: 887-895.
11. Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analysis of the published literature. Clin Infect Dis 2005; 41: 217-224.
12. Dabis F, Schechter M, Egger M, and ART-LINC/ART-CC Study Groups. Response to highly active retroviral therapy in low- and high-income countries: Analysis from 4 continents. Abstracts of the 12th Conference on Retroviruses and Opportunistic Infections, 22-25 February 2005, Boston. Abstract no. 23, p. 73.
13. Severe P, Leger P, Charles M, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005; 353: 2325-2334.
14. Yong Kim JY, Gilks C. Scaling up treatment - why we can't wait. N Engl J Med 2005; 353: 2392-2394.
15. Adam T, Amorim DG, Edwards SJ, Amaral J, Evans DB. Capacity constraints to the adoption of new interventions: Consultation time and the Integrated Management of Childhood Illness in Brazil. Health Policy Plan 2005; 20: Suppl 1, i49-i57.
16. Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-Saharan Africa: Impact on patients and programmes; implications for policies. Trop Med Int Health 2005; 10: 734-742.
17. Mathews C, van Rensburg A, Schierhout G, et al. An assessment of care provided by a public sector STD clinic in Cape Town. Int J STD AIDS 1998; 9: 689-694.
18. City of Cape Town. Nyanga district population 2003. http://www.capetown.gov.za (last accessed 27 July 2005).
19. Statistics SA. South African 2001 national census. http://www.statssa.gov.za/census01/html/c2001Ward.asp (last accessed 27 July 2005).
20. Health Systems Trust. Cape Town TB Control. Progress report 1997 - 2003. http://www.hst.org.za/publications (last accessed 27 July 2005).
21. Uys P, Minister of Health. Agreement to strengthen HIV and AIDS programme. http://www.info.gov.za/speaches/2004/041022151510.htm (last accessed 27 July 2005).
22. Bekker L-G, Orrell C, Reader L, et al. Antiretroviral therapy in a community clinic: Early lessons from a pilot project. S Afr Med J 2003; 93: 458-462.
23. National Department of Health, South Africa. National Antiretrovial Treatment Guidelines. 1st ed. Pretoria: DOH, 2004.
24. World Health Organization. Scaling up Antiretroviral Therapy in Resource-limited Settings: Guidelines for a Public Health Approach; Executive Summary. Geneva: WHO, 2002. www.who.int/medicinedocs/library.fcgl?e=d-Oedmweb (last accessed 15 April 2005).
25. Sabin C, on behalf of the Antiretroviral Therapy Cohort Collaboration. AIDS events among individuals initiating HAART: Do some patients experience a greater benefit from HAART than others? AIDS 2005; 19: 1995-2000.
26. Lawn SD, Myer L, Orrel CL, Bekker L-G, Wood R. Early mortality among patients accessing a community-based antiretroviral service in South Africa: Implications for program design. AIDS 2005; 19: 2141-2148.
27. International Treatment Preparedness Coalition (ITPC). Missing the target. A report on HIV/AIDS treatment access from the frontlines. http://www.tac.org.za (last accessed 28 November 2005).